301111 Stock Overview
Engages in the research, development, production, and sale of pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Guangdong Lifestrong Pharmacy Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.04 |
| 52 Week High | CN¥33.47 |
| 52 Week Low | CN¥11.20 |
| Beta | 0.84 |
| 11 Month Change | -5.59% |
| 3 Month Change | 3.42% |
| 1 Year Change | -20.12% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -51.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301111 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -7.3% | -1.9% | -1.2% |
| 1Y | -20.1% | -5.0% | 3.1% |
Return vs Industry: 301111 underperformed the CN Pharmaceuticals industry which returned -4.9% over the past year.
Return vs Market: 301111 underperformed the CN Market which returned 5.7% over the past year.
Price Volatility
| 301111 volatility | |
|---|---|
| 301111 Average Weekly Movement | 9.1% |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in CN Market | 12.0% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 301111 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301111's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 522 | Ou Xiantao | www.wnqzy.com.cn |
Guangdong Lifestrong Pharmacy Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. The company produces tablets, pills, injection, mixture, granules, and other related products. It also offers respiratory, pediatric, gynecology, urinary, and nutrition and healthcare category products.
Guangdong Lifestrong Pharmacy Co., Ltd. Fundamentals Summary
| 301111 fundamental statistics | |
|---|---|
| Market cap | CN¥2.57b |
| Earnings (TTM) | CN¥17.11m |
| Revenue (TTM) | CN¥315.10m |
150.0x
P/E Ratio8.1x
P/S RatioIs 301111 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301111 income statement (TTM) | |
|---|---|
| Revenue | CN¥315.10m |
| Cost of Revenue | CN¥119.90m |
| Gross Profit | CN¥195.20m |
| Other Expenses | CN¥178.09m |
| Earnings | CN¥17.11m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 61.95% |
| Net Profit Margin | 5.43% |
| Debt/Equity Ratio | 0.2% |
How did 301111 perform over the long term?
See historical performance and comparison